Olivier Blondel

Title: Olivier Blondel: Innovator in Serotonin Receptor Research

Introduction

Olivier Blondel is a prominent inventor based in Washington, DC, known for his significant contributions to the field of serotonin receptor research. His work focuses on the intricate mechanisms of the human 5-HT4 serotonin receptor, which plays a crucial role in various physiological processes.

Latest Patents

Olivier Blondel holds a patent for "Splice variants for human 5-HT4 serotonin receptor and their applications, in particular for screening." This invention concerns an isolated polypeptide constitutive of splice variants for the human serotonin receptor, where the amino acid sequence is selected among the sequence SEQ ID No. 2 of the 5-HT polypeptide variant or the sequence SEQ ID No. 4 of the 5-HT polypeptide variant, or any polypeptide fragment or biologically active derivative thereof. The invention also explores the inverse agonist effect of ML 10375 on 5-HT4(c) and 5-HT4(d) receptors. Olivier has 1 patent to his name.

Career Highlights

Olivier Blondel is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he conducts his research. His work has contributed to a deeper understanding of serotonin receptors and their potential applications in medical science.

Collaborations

Throughout his career, Olivier has collaborated with notable colleagues, including Rodolphe Fischmeister and Michel Langlois. These collaborations have further enriched his research and innovation in the field.

Conclusion

Olivier Blondel's contributions to serotonin receptor research exemplify the impact of innovative thinking in the medical field. His patent and ongoing research continue to pave the way for advancements in understanding and treating related health conditions.